The Value of BCG and TNF in Autoimmunity

Nonfiction, Health & Well Being, Medical, Medical Science, Immunology, Science & Nature, Science
Cover of the book The Value of BCG and TNF in Autoimmunity by , Elsevier Science
View on Amazon View on AbeBooks View on Kobo View on B.Depository View on eBay View on Walmart
Author: ISBN: 9780128004616
Publisher: Elsevier Science Publication: March 13, 2014
Imprint: Academic Press Language: English
Author:
ISBN: 9780128004616
Publisher: Elsevier Science
Publication: March 13, 2014
Imprint: Academic Press
Language: English

The Value of BCG and TNF in Autoimmunity provides an overview of current research and thinking related to tumor necrosis factor (TNF) induction and the use of the bacillus Calmette-Guérin (BCG) vaccine as potential treatment approaches to diverse forms of autoimmunity. BCG, commonly known as an anti-tuberculosis vaccine, is being explored in worldwide clinical trials as an approach to the treatment of certain forms of autoimmunity. The scope of research behind this therapeutic approach spans from the basic science of TNF signaling to research in diverse autoimmune disciplines, such as type 1 diabetes and multiple sclerosis.

Overall, the book focuses on the lessons that can be learned from the researchers' individual experiences and data, and provides a rationale for bringing the inexpensive, generic BCG vaccine to the forefront of clinical trials in different forms of autoimmunity.

  • Editor awarded 2005: Oprah Achievement Award," Top Health Breakthrough by a Female Scientist"
  • Brings into one resource the international scientific literature on a unique way to treat autoimmunity
  • Provides a different perspective on treatment approaches for certain autoimmune conditions
  • Discusses TNF induction, rather than anti-TNF, as a therapeutic pathway for autoimmunity treatment
View on Amazon View on AbeBooks View on Kobo View on B.Depository View on eBay View on Walmart

The Value of BCG and TNF in Autoimmunity provides an overview of current research and thinking related to tumor necrosis factor (TNF) induction and the use of the bacillus Calmette-Guérin (BCG) vaccine as potential treatment approaches to diverse forms of autoimmunity. BCG, commonly known as an anti-tuberculosis vaccine, is being explored in worldwide clinical trials as an approach to the treatment of certain forms of autoimmunity. The scope of research behind this therapeutic approach spans from the basic science of TNF signaling to research in diverse autoimmune disciplines, such as type 1 diabetes and multiple sclerosis.

Overall, the book focuses on the lessons that can be learned from the researchers' individual experiences and data, and provides a rationale for bringing the inexpensive, generic BCG vaccine to the forefront of clinical trials in different forms of autoimmunity.

More books from Elsevier Science

Cover of the book Antiviral Agents by
Cover of the book Sensor Technologies for Civil Infrastructures, Volume 1 by
Cover of the book Quaternary Coral Reef Systems by
Cover of the book Advanced Industrial Control Technology by
Cover of the book New and Future Developments in Microbial Biotechnology and Bioengineering by
Cover of the book Regulatory T-Cells by
Cover of the book Renewable Energy by
Cover of the book Matlab by
Cover of the book Discrete-Time Control System Analysis and Design by
Cover of the book Diabetes by
Cover of the book Engineering Rock Mass Classification by
Cover of the book Advances in Imaging and Electron Physics by
Cover of the book Annual Reports on NMR Spectroscopy by
Cover of the book The Neurobiology of Multiple Sclerosis by
Cover of the book Advances in Organometallic Chemistry by
We use our own "cookies" and third party cookies to improve services and to see statistical information. By using this website, you agree to our Privacy Policy